Christine Ring - Sep 7, 2021 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role: General Counsel
Signature: /s/ Christine Ring
Stock symbol: NRIX
Transactions as of: Sep 7, 2021
Transactions value $: -$106,848
Form type: 4
Date filed: 9/8/2021, 05:08 PM
Previous filing: Aug 11, 2021
Next filing: Sep 13, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NRIX	Common Stock	Options Exercise	$5.95K	+3.2K	+248.83%	$1.86^*	4.49K	Sep 7, 2021	Direct	F1, F2
transaction	NRIX	Common Stock	Sale	-$113K	-3.2K	-71.33%	$35.25	1.29K	Sep 7, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRIX	Employee Stock Option (right to buy)	Options Exercise	$0	-3.2K	-2.89%	$0.00	108K	Sep 7, 2021	Common Stock	3.2K	$1.86	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2	Includes 481 shares of Common Stock acquired by the Reporting Person on August 13, 2021 pursuant to the Issuer's employee stock purchase plan.
F3	The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.